Therapeutics: MicroRNA-9 (miR-9); miR-200c

Patient sample and mouse studies suggest inhibiting miR-9 or promoting miR-200c expression could help treat triple-negative breast cancer (TNBC). In patient samples, high tumor miR-9 levels correlated...